有远期脑血管事件史的无症状颈动脉狭窄患者较无事件史的无症状患者主要不良事件风险增高
基于血管质量倡议数据库,比较经颈动脉血运重建(TCAR)与经股动脉颈动脉支架置入(TFCAS)在有症状、有远期神经症状史的无症状及无事件史的无症状颈动脉狭窄患者中的院内结局。有远期神经症状史者发生TIA、卒中、TIA/卒中、卒中/死亡及卒中/死亡/心肌梗死的发生率高于无事件史的无症状患者,与有症状患者相似;在该组中TCAR较TFCAS的卒中/死亡及卒中/死亡/心肌梗死风险降低。
要点
- 有远期TIA/卒中史的无症状患者不良事件风险高于无事件史的无症状患者,与有症状患者相似。
- 有远期神经症状史者中,TCAR较TFCAS的卒中/死亡风险降低(OR 0.46,95%CI 0.27-0.84,P=0.011)。
- 有远期神经症状史者中,TCAR较TFCAS的卒中/死亡/心肌梗死风险降低(OR 0.51,95%CI 0.30-0.87,P=0.013)。
核心结论
- 有远期TIA/卒中史的无症状颈动脉狭窄患者与无事件史的无症状患者结局不同,院内不良事件风险更高。
- 有远期TIA/卒中史者TFCAS后院内死亡风险增高,可能从TCAR获益。
研究设计与样本
- 回顾性分析血管质量倡议数据库中2017年1月至2020年4月接受TCAR及2005年5月至2020年4月接受TFCAS的患者数据。
- TCAR共7158例(有症状2574例、无症状3689例、有远期神经症状史的无症状895例)。
- TFCAS共18023例(有症状6195例、无症状10333例、有远期神经症状史的无症状1495例)。
- 有症状定义为术前180天内发生TIA和/或卒中;有远期神经症状史定义为术前超过180天发生TIA/卒中。
- 采用Student t检验和Pearson χ2检验比较基线特征与结局,多因素logistic回归校正组间基线差异。
主要发现
- TCAR组平均年龄73岁,TFCAS组平均年龄69岁;男性占64%,女性占36%。
- 三个患者组平均长期随访数据在208至331天之间。
- 有远期神经症状史的无症状患者TIA、卒中、TIA/卒中、卒中/死亡、卒中/死亡/心肌梗死发生率均高于无事件史的无症状患者,与有症状患者相似。
- 有远期神经症状史者中,TCAR较TFCAS的卒中/死亡风险降低(OR 0.46,95%CI 0.27-0.84,P=0.011)。
- 有远期神经症状史者中,TCAR较TFCAS的卒中/死亡/心肌梗死风险降低(OR 0.51,95%CI 0.30-0.87,P=0.013);TFCAS后有远期神经症状史者死亡率0.9%,无事件史的无症状患者0.6%。
临床怎么用
- 作者认为,有远期TIA/卒中史的无症状患者TFCAS后院内死亡风险增高,可能从TCAR获益。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
INTRODUCTION: Asymptomatic patients with a remote history of transient ischemic attack (TIA) or stroke are not well studied as a separate population from asymptomatic patients with no prior history of TIA or stroke. We compared in-hospital outcomes after transcarotid artery revascularization (TCAR) and transfemoral carotid artery stenting (TFCAS) among symptomatic patients, patients with a remote history of neurologic symptoms, and asymptomatic patients. METHODS: Data from patients in the Vascular Quality Initiative database who underwent TCAR (January 2017 to April 2020) or TFCAS (May 2005 to April 2020) were analyzed. Symptomatic status was defined as TIA and/or stroke occurring within 180 days before the procedure. Asymptomatic status was divided into patients with no history of TIA/stroke (asymptomatic) and patients with a history of TIA/stroke occurring more than 180 days before the procedure (remote history of neurologic symptoms). The Student t-test and Pearson χ2 test were used to compare baseline patient characteristics and outcomes. Multivariate logistic regression was used to adjust for significant between-group differences in baseline characteristics. RESULTS: There were 7158 patients who underwent TCAR (symptomatic: 2574, asymptomatic: 3689, and asymptomatic with a remote history of neurologic symptoms: 895) and 18,023 patients who underwent TFCAS (symptomatic: 6195, asymptomatic: 10,333, and asymptomatic with a remote history of neurologic symptoms: 1495). Regardless of symptom status, the mean patient age was 73 years for TCAR and 69 years for TFCAS. A total of 64% of patients in the study were male and 36% of patients were female. The mean long-term follow-up data ranged between 208 and 331 days within the three patient groups. Carotid stenosis patients with a remote history of neurologic symptoms had higher rates of TIA, stroke, TIA/stroke, stroke/death, and stroke/death/myocardial infarction than asymptomatic patients, and these rates were similar to those of symptomatic patients. Comparing TCAR and TFCAS among patients with a remote history of neurologic symptoms, there were statistically significant reductions in the odds of stroke/death (odds ratio: 0.46, 95% confidence interval: 0.27-0.84, P = .011) and stroke/death/myocardial infarction (odds ratio: 0.51, 95% confidence interval: 0.30-0.87, P = .013) after TCAR. This was likely driven by the increased rate of death after TFCAS in patients with a remote history of neurologic symptoms (0.9%) compared with asymptomatic patients (0.6%). CONCLUSIONS: Asymptomatic patients with a remote history of TIA/stroke do not have the same outcomes as asymptomatic patients without a history of TIA/stroke and are at higher risk of adverse in-hospital events. Patients with a remote history of TIA/stroke have increased risk of in-hospital death after TFCAS and may benefit from TCAR.
引用
- Turner AD, Zhu J, Rao A, et al. Carotid stenosis patients with a remote history of cerebrovascular events have increased risk of major adverse events over asymptomatic patients. J Vasc Surg. 2022. PMID: 35868422. doi:10.1016/j.jvs.2022.07.013
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。